Annals of Thoracic Medicine
LETTER TO THE EDITOR
Year
: 2012  |  Volume : 7  |  Issue : 3  |  Page : 171-

Serum hepcidin and chronic obstructive pulmonary disease


Beuy Joob1, Viroj Wiwanitkit2,  
1 Sanitation, Medical Academic Center, Bangkok, Thailand
2 Wiwanitkit House, Bangkhae, Bangkok, Thailand

Correspondence Address:
Beuy Joob
Sanitation, Medical Academic Center, Bangkok
Thailand




How to cite this article:
Joob B, Wiwanitkit V. Serum hepcidin and chronic obstructive pulmonary disease.Ann Thorac Med 2012;7:171-171


How to cite this URL:
Joob B, Wiwanitkit V. Serum hepcidin and chronic obstructive pulmonary disease. Ann Thorac Med [serial online] 2012 [cited 2021 Apr 20 ];7:171-171
Available from: https://www.thoracicmedicine.org/text.asp?2012/7/3/171/98855


Full Text

Sir,

The recent report on serum hepcidin and COPD is very interesting. [1] Duru et al. concluded that "serum hepcidin level may be a useful marker in COPD." [1] As Duru et al. proposed, a further confirmation is required. An important point is there is no complete assessment on hepatitis profile (such as hepatitis B, hepatitis C, etc.) needed. Also, some genetic disorders can also alter the hepcidin level that has to be ruled out. Thalassemia [2] as well as some other rare genetic mutations [3] should be ruled out. It is still very inconclusive to conclude for any usefulness of hepcidin as a new biomarker for COPD.

References

1Duru S, Bilgin E, Ardiç S. Hepcidin: A useful marker in chronic obstructive pulmonary disease. Ann Thorac Med 2012;7:31-5.
2Origa R, Galanello R. Pathophysiology of beta thalassaemia. Pediatr Endocrinol Rev 2011;8 (Suppl 2):263-70.
3Melis MA, Cau M, Congiu R, Sole G, Barella S, Cao A, et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008;93:1473-9.